SARS-CoV-2-IN-13
SARS-CoV-2-IN-13 (compound 5) is a niclosamide analogue demonstrating enhanced metabolic stability in human plasma and liver S9 fractions, leading to improved oral bioavailability and half-life. This potent antiviral agent inhibits SARS-CoV-2 with an IC50 of 0.057 μM, supporting its investigation in both in vitro and in vivo antiviral research models.
Product Specifications
CAS Number
56961-10-5
Product Name Alternative
SARS-CoV-2, SARSCoV
Field of Research
Infectious Disease & Virology
Purity
98.15% (May vary between batches)
Solubility
DMSO:112.5 mg/mL (343.91 mM)
Smiles
Oc1ccc (Cl) cc1C (=O) Nc1ccc (c (Cl) c1) [N+] ([O-]) =O
Molecular Formula
C13H8Cl2N2O4
Molecular Weight
327.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-43600R-BF405-TR 20 µL
Osteopontin Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details 
YP-W36176-01 48 Tests
Rat Multidrug Resistance Associated Protein 1 (MRP1) ELISA Kit
Sign In for Pricing
View Details YP-W36176-02 96 Tests
Rat Multidrug Resistance Associated Protein 1 (MRP1) ELISA Kit
Sign In for Pricing
View Details 
GTR15198404 1 Vial
Lentiviral mouse Ablim3 shRNA (UAS) - Lentiviral mouseAblim3 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details